Apyx Medical Statistics

Total Valuation

Apyx Medical has a market cap or net worth of $81.63 million. The enterprise value is $90.67 million.

Market Cap	81.63M
Enterprise Value	90.67M

Important Dates

The next estimated earnings date is Thursday, August 7, 2025, after market close.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Apyx Medical has 37.79 million shares outstanding. The number of shares has increased by 7.02% in one year.

Current Share Class	37.79M
Shares Outstanding	37.79M
Shares Change (YoY)	+7.02%
Shares Change (QoQ)	+6.58%
Owned by Insiders (%)	14.56%
Owned by Institutions (%)	24.46%
Float	25.50M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.76
Forward PS	1.66
PB Ratio	8.05
P/TBV Ratio	7.87
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.92
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.45, with a Debt / Equity ratio of 3.66.

Current Ratio	5.45
Quick Ratio	4.49
Debt / Equity	3.66
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2.60

Financial Efficiency

Return on equity (ROE) is -129.51% and return on invested capital (ROIC) is -17.58%.

Return on Equity (ROE)	-129.51%
Return on Assets (ROA)	-14.60%
Return on Invested Capital (ROIC)	-17.58%
Return on Capital Employed (ROCE)	-30.17%
Revenue Per Employee	$214,945
Profits Per Employee	-$91,077
Employee Count	220
Asset Turnover	0.72
Inventory Turnover	2.08

Taxes

In the past 12 months, Apyx Medical has paid $248,000 in taxes.

Income Tax	248,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +60.00% in the last 52 weeks. The beta is 1.20, so Apyx Medical's price volatility has been higher than the market average.

Beta (5Y)	1.20
52-Week Price Change	+60.00%
50-Day Moving Average	1.47
200-Day Moving Average	1.37
Relative Strength Index (RSI)	61.66
Average Volume (20 Days)	71,978

Short Selling Information

The latest short interest is 212,930, so 0.56% of the outstanding shares have been sold short.

Short Interest	212,930
Short Previous Month	299,311
Short % of Shares Out	0.56%
Short % of Float	0.83%
Short Ratio (days to cover)	0.52

Income Statement

In the last 12 months, Apyx Medical had revenue of $47.29 million and -$20.04 million in losses. Loss per share was -$0.54.

Revenue	47.29M
Gross Profit	29.08M
Operating Income	-15.28M
Pretax Income	-28.50M
Net Income	-20.04M
EBITDA	-14.70M
EBIT	-15.28M
Loss Per Share	-$0.54

Full Income Statement

Balance Sheet

The company has $31.01 million in cash and $38.92 million in debt, giving a net cash position of -$7.91 million or -$0.21 per share.

Cash & Cash Equivalents	31.01M
Total Debt	38.92M
Net Cash	-7.91M
Net Cash Per Share	-$0.21
Equity (Book Value)	10.64M
Book Value Per Share	0.28
Working Capital	42.34M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$12.41 million and capital expenditures -$742,000, giving a free cash flow of -$13.15 million.

Operating Cash Flow	-12.41M
Capital Expenditures	-742,000
Free Cash Flow	-13.15M
FCF Per Share	-$0.35

Full Cash Flow Statement

Margins

Gross margin is 61.49%, with operating and profit margins of -32.31% and -42.37%.

Gross Margin	61.49%
Operating Margin	-32.31%
Pretax Margin	-42.07%
Profit Margin	-42.37%
EBITDA Margin	-31.09%
EBIT Margin	-32.31%
FCF Margin	n/a

Dividends & Yields

Apyx Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.02%
Shareholder Yield	-7.02%
Earnings Yield	-24.21%
FCF Yield	-15.89%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	Hold
Analyst Count	2
Revenue Growth Forecast (5Y)	41.47%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 6, 1994. It was a reverse split with a ratio of 0.06666:1.

Last Split Date	Jan 6, 1994
Split Type	Reverse
Split Ratio	0.06666:1

Scores

Apyx Medical has an Altman Z-Score of -0.52 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.52
Piotroski F-Score	1